• AstraZeneca strikes mRNA-based partnership in respiratory disease pharmatimes
    August 23, 2017
    AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist Ethris to leverage the latter’s proprietary SNIM RNA technology in the...
PharmaSources Customer Service